New Blood Test Shows Promise in Distinguishing Unipolar and Bipolar Depression
PARIS, Oct. 15, 2025 /PRNewswire/ — The world’s first blood test designed to help clinicians distinguish unipolar depression from bipolar disorder, myEDIT-B, has demonstrated a high level of acceptability and clinical utility to psychiatrists and thier patients in a European real-world study. Based on RNA editing and artificial intelligence, the myEDIT-B test reflects an emerging focus on precision psychiatry, providing a biological tool that complements clinical diagnosis.
As part of Clariane’s approach to evaluating health innovations, an acceptability study accompanied the rollout of the myEDIT-B test, which was prescribed…
ALCEDIAG Receives Poster Prize at Clariane Scientific Day
Paris, France – October 15, 2025 12:50:59 – ALCEDIAG, a diagnostic company focused on precision psychiatry, announced today that it received a poster prize at the Clariane Scientific Day held at Paris Cité University. The research presented was selected by the event’s scientific committee and recognized for its innovation.
about ALCEDIAG
ALCEDIAG is a pioneering diagnostic company dedicated to transforming mental health through precision psychiatry. The company develops and markets innovative in vitro diagnostic tests based on cutting-edge molecular biology and artificial intelligence. Its proprietary platform uses biomarkers based on RNA editing to develop objective tools suitable for clinical practice in psychiatry.
About clariane
Clariane is the leading european community of care in times of vulnerability, operating in Belgium, France, Germany, Italy, the Netherlands, and Spain. The Group’s 63,000 professionals provide services to nearly 900,000 patients and residents annually across care homes (Korian, Seniors Residencias, etc.), healthcare facilities and services (Inicea, Ita, Grupo 5, Lebenswert, etc.), and choice living solutions (Âges & Vie, etc.).
In June 2023, Clariane adopted a purpose-driven approach, adding a corporate purpose to its bylaws: “To take care of each person’s humanity in times of vulnerability.”